{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:47:46Z","timestamp":1785257266727,"version":"3.55.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2018YFE0118900"],"award-info":[{"award-number":["2018YFE0118900"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870825"],"award-info":[{"award-number":["31870825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shenzhen-Hong Kong Institute of Brain Science-Shenzhen Fundamental Research Institutions","award":["2021SHIBS0003"],"award-info":[{"award-number":["2021SHIBS0003"]}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20170412110026229"],"award-info":[{"award-number":["JCYJ20170412110026229"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s12035-023-03533-2","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:01:42Z","timestamp":1691539302000},"page":"7309-7328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Targeted Metabolomic Analysis of the Eye Tissue of Triple Transgenic Alzheimer\u2019s Disease Mice at an Early Pathological Stage"],"prefix":"10.1007","volume":"60","author":[{"given":"Liming","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8501-5177","authenticated-orcid":false,"given":"Xukun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"3533_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrneurol.2017.162","volume":"14","author":"JC Polanco","year":"2018","unstructured":"Polanco JC, Li C, Bodea L-G et al (2018) Amyloid-\u03b2 and tau complexity \u2014 towards improved biomarkers and targeted therapies. Nat Rev Neurol 14:22\u201339. https:\/\/doi.org\/10.1038\/nrneurol.2017.162","journal-title":"Nat Rev Neurol"},{"key":"3533_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13195-017-0297-z","volume":"9","author":"M Crous-Bou","year":"2017","unstructured":"Crous-Bou M, Minguill\u00f3n C, Gramunt N, Molinuevo JL (2017) Alzheimer\u2019s disease prevention: from risk factors to early intervention. Alzheimers Res Ther 9:71. https:\/\/doi.org\/10.1186\/s13195-017-0297-z","journal-title":"Alzheimers Res Ther"},{"key":"3533_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.3233\/JAD-191034","volume":"74","author":"T Soares Martins","year":"2020","unstructured":"Soares Martins T, Magalh\u00e3es S, Rosa IM et al (2020) Potential of FTIR spectroscopy applied to exosomes for Alzheimer\u2019s disease discrimination: a pilot study. J Alzheimers Dis JAD 74:391\u2013405. https:\/\/doi.org\/10.3233\/JAD-191034","journal-title":"J Alzheimers Dis JAD"},{"key":"3533_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jalz.2019.05.002","volume":"15","author":"L Jia","year":"2019","unstructured":"Jia L, Qiu Q, Zhang H et al (2019) Concordance between the assessment of A\u03b242, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement J Alzheimers Assoc 15:1071\u20131080. https:\/\/doi.org\/10.1016\/j.jalz.2019.05.002","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"3533_CR5","doi-asserted-by":"publisher","unstructured":"Shen L, Xia S, Zhang H et al (2018) Precision medicine: role of biomarkers in early prediction and diagnosis of Alzheimer\u2019s disease. Mol Med. https:\/\/doi.org\/10.5772\/intechopen.82035","DOI":"10.5772\/intechopen.82035"},{"key":"3533_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3233\/JAD-160913","volume":"56","author":"L Shen","year":"2017","unstructured":"Shen L, Liao L, Chen C et al (2017) Proteomics analysis of blood serums from Alzheimer\u2019s disease patients using iTRAQ labeling technology. J Alzheimers Dis JAD 56:361\u2013378. https:\/\/doi.org\/10.3233\/JAD-160913","journal-title":"J Alzheimers Dis JAD"},{"key":"3533_CR7","doi-asserted-by":"publisher","first-page":"77sr1","DOI":"10.1126\/scitranslmed.3002369","volume":"3","author":"DM Holtzman","year":"2011","unstructured":"Holtzman DM, Morris JC, Goate AM (2011) Alzheimer\u2019s disease: the challenge of the second century. Sci Transl Med 3:77sr1. https:\/\/doi.org\/10.1126\/scitranslmed.3002369","journal-title":"Sci Transl Med"},{"key":"3533_CR8","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1212\/wnl.38.11.1682","volume":"38","author":"H Crystal","year":"1988","unstructured":"Crystal H, Dickson D, Fuld P et al (1988) Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer\u2019s disease. Neurology 38:1682\u20131687. https:\/\/doi.org\/10.1212\/wnl.38.11.1682","journal-title":"Neurology"},{"key":"3533_CR9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin RJ, Fagan AM, Holtzman DM (2009) Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease. Nature 461:916\u2013922. https:\/\/doi.org\/10.1038\/nature08538","journal-title":"Nature"},{"key":"3533_CR10","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1093\/jnen\/62.11.1087","volume":"62","author":"DS Knopman","year":"2003","unstructured":"Knopman DS, Parisi JE, Salviati A et al (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62:1087\u20131095. https:\/\/doi.org\/10.1093\/jnen\/62.11.1087","journal-title":"J Neuropathol Exp Neurol"},{"key":"3533_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1385\/JMN:17:2:101","volume":"17","author":"JC Morris","year":"2001","unstructured":"Morris JC, Price JL (2001) Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer\u2019s disease. J Mol Neurosci 17:101\u2013118. https:\/\/doi.org\/10.1385\/JMN:17:2:101","journal-title":"J Mol Neurosci"},{"key":"3533_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jalz.2013.06.004","volume":"10","author":"LYL Chang","year":"2014","unstructured":"Chang LYL, Lowe J, Ardiles A et al (2014) Alzheimer\u2019s disease in the human eye. Clinical tests that identify ocular and visual information processing deficit as biomarkers. Alzheimers Dement 10:251\u2013261. https:\/\/doi.org\/10.1016\/j.jalz.2013.06.004","journal-title":"Alzheimers Dement"},{"key":"3533_CR13","doi-asserted-by":"publisher","first-page":"5416","DOI":"10.1007\/s12035-018-1461-6","volume":"56","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Rodrigues-Neves AC, Baptista FI et al (2019) The retina as a window or mirror of the brain changes detected in Alzheimer\u2019s disease: critical aspects to unravel. Mol Neurobiol 56:5416\u20135435. https:\/\/doi.org\/10.1007\/s12035-018-1461-6","journal-title":"Mol Neurobiol"},{"key":"3533_CR14","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/cells10092394","volume":"10","author":"N Marchesi","year":"2021","unstructured":"Marchesi N, Fahmideh F, Boschi F et al (2021) Ocular neurodegenerative diseases: interconnection between retina and cortical areas. Cells 10:2394. https:\/\/doi.org\/10.3390\/cells10092394","journal-title":"Cells"},{"issue":"Suppl 1","key":"3533_CR15","doi-asserted-by":"publisher","first-page":"S204","DOI":"10.1016\/j.neuroimage.2010.06.020","volume":"54","author":"M Koronyo-Hamaoui","year":"2011","unstructured":"Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV et al (2011) Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage 54(Suppl 1):S204-217. https:\/\/doi.org\/10.1016\/j.neuroimage.2010.06.020","journal-title":"Neuroimage"},{"key":"3533_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.3389\/fnins.2020.00921","volume":"14","author":"N Mirzaei","year":"2020","unstructured":"Mirzaei N, Shi H, Oviatt M et al (2020) Alzheimer\u2019s retinopathy: seeing disease in the eyes. Front Neurosci 14:921. https:\/\/doi.org\/10.3389\/fnins.2020.00921","journal-title":"Front Neurosci"},{"key":"3533_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00401-016-1613-6","volume":"132","author":"NJ Hart","year":"2016","unstructured":"Hart NJ, Koronyo Y, Black KL, Koronyo-Hamaoui M (2016) Ocular indicators of Alzheimer\u2019s: exploring disease in the retina. Acta Neuropathol (Berl) 132:767\u2013787. https:\/\/doi.org\/10.1007\/s00401-016-1613-6","journal-title":"Acta Neuropathol (Berl)"},{"key":"3533_CR18","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fnagi.2019.00309","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wei W, Baazaoui N et al (2019) Inhibition of AMD-like pathology with a neurotrophic compound in aged rats and 3xTg-AD mice. Front Aging Neurosci 11:309. https:\/\/doi.org\/10.3389\/fnagi.2019.00309","journal-title":"Front Aging Neurosci"},{"key":"3533_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","volume":"6","author":"J den Haan","year":"2018","unstructured":"den Haan J, Morrema THJ, Verbraak FD et al (2018) Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas. Acta Neuropathol Commun 6:147. https:\/\/doi.org\/10.1186\/s40478-018-0650-x","journal-title":"Acta Neuropathol Commun"},{"key":"3533_CR20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1167\/iovs.13-12888","volume":"55","author":"Y Tsai","year":"2014","unstructured":"Tsai Y, Lu B, Ljubimov AV et al (2014) Ocular changes in TgF344-AD rat model of Alzheimer\u2019s disease. Invest Ophthalmol Vis Sci 55:523\u2013534. https:\/\/doi.org\/10.1167\/iovs.13-12888","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3533_CR21","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2217\/nmt.14.19","volume":"4","author":"MH Dehabadi","year":"2014","unstructured":"Dehabadi MH, Davis BM, Wong TK, Cordeiro MF (2014) Retinal manifestations of Alzheimer\u2019s disease. Neurodegener Dis Manag 4:241\u2013252. https:\/\/doi.org\/10.2217\/nmt.14.19","journal-title":"Neurodegener Dis Manag"},{"key":"3533_CR22","doi-asserted-by":"publisher","first-page":"93621","DOI":"10.1172\/jci.insight.93621","volume":"2","author":"Y Koronyo","year":"2017","unstructured":"Koronyo Y, Biggs D, Barron E et al (2017) Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease. JCI Insight 2:93621. https:\/\/doi.org\/10.1172\/jci.insight.93621","journal-title":"JCI Insight"},{"key":"3533_CR23","doi-asserted-by":"publisher","first-page":"e53547","DOI":"10.1371\/journal.pone.0053547","volume":"7","author":"C Sch\u00f6n","year":"2012","unstructured":"Sch\u00f6n C, Hoffmann NA, Ochs SM et al (2012) Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice. PLoS One 7:e53547. https:\/\/doi.org\/10.1371\/journal.pone.0053547","journal-title":"PLoS One"},{"key":"3533_CR24","doi-asserted-by":"publisher","unstructured":"Lim JKH, Li Q-X, He Z et al (2016) The eye as a biomarker for Alzheimer\u2019s disease. Front Neurosci 10:536. https:\/\/doi.org\/10.3389\/fnins.2016.00536","DOI":"10.3389\/fnins.2016.00536"},{"key":"3533_CR25","doi-asserted-by":"publisher","first-page":"e12232","DOI":"10.1002\/dad2.12232","volume":"13","author":"L Csincsik","year":"2021","unstructured":"Csincsik L, Quinn N, Yong KXX et al (2021) Retinal phenotyping of variants of Alzheimer\u2019s disease using ultra-widefield retinal images. Alzheimers Dement Amst Neth 13:e12232. https:\/\/doi.org\/10.1002\/dad2.12232","journal-title":"Alzheimers Dement Amst Neth"},{"key":"3533_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11357-020-00252-7","volume":"42","author":"C Czak\u00f3","year":"2020","unstructured":"Czak\u00f3 C, Kov\u00e1cs T, Ungvari Z et al (2020) Retinal biomarkers for Alzheimer\u2019s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis. GeroScience 42:1499\u20131525. https:\/\/doi.org\/10.1007\/s11357-020-00252-7","journal-title":"GeroScience"},{"key":"3533_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/alz.12179","volume":"17","author":"PJ Snyder","year":"2021","unstructured":"Snyder PJ, Alber J, Alt C et al (2021) Retinal imaging in Alzheimer\u2019s and neurodegenerative diseases. Alzheimers Dement J Alzheimers Assoc 17:103\u2013111. https:\/\/doi.org\/10.1002\/alz.12179","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"3533_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.3389\/fnagi.2018.00188","volume":"10","author":"H Liao","year":"2018","unstructured":"Liao H, Zhu Z, Peng Y (2018) Potential utility of retinal imaging for Alzheimer\u2019s disease: a review. Front Aging Neurosci 10:188. https:\/\/doi.org\/10.3389\/fnagi.2018.00188","journal-title":"Front Aging Neurosci"},{"key":"3533_CR29","doi-asserted-by":"publisher","first-page":"101361","DOI":"10.1016\/j.arr.2021.101361","volume":"69","author":"Y-J Ge","year":"2021","unstructured":"Ge Y-J, Xu W, Ou Y-N et al (2021) Retinal biomarkers in Alzheimer\u2019s disease and mild cognitive impairment: a systematic review and meta-analysis. Ageing Res Rev 69:101361. https:\/\/doi.org\/10.1016\/j.arr.2021.101361","journal-title":"Ageing Res Rev"},{"key":"3533_CR30","doi-asserted-by":"publisher","first-page":"251584142095050","DOI":"10.1177\/2515841420950508","volume":"12","author":"S Asanad","year":"2020","unstructured":"Asanad S, Mohammed I, Sadun AA, Saeedi OJ (2020) OCTA in neurodegenerative optic neuropathies: emerging biomarkers at the eye-brain interface. Ther Adv Ophthalmol 12:2515841420950508. https:\/\/doi.org\/10.1177\/2515841420950508","journal-title":"Ther Adv Ophthalmol"},{"key":"3533_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/WNO.0000000000001140","volume":"41","author":"H Jiang","year":"2021","unstructured":"Jiang H, Wang J, Levin BE et al (2021) Retinal microvascular alterations as the biomarkers for Alzheimer disease: are we there yet? J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc 41:251\u2013260. https:\/\/doi.org\/10.1097\/WNO.0000000000001140","journal-title":"J Neuro-Ophthalmol Off J North Am Neuro-Ophthalmol Soc"},{"key":"3533_CR32","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40478-020-01094-2","volume":"8","author":"RJ Bevan","year":"2020","unstructured":"Bevan RJ, Hughes TR, Williams PA et al (2020) Retinal ganglion cell degeneration correlates with hippocampal spine loss in experimental Alzheimer\u2019s disease. Acta Neuropathol Commun 8:216. https:\/\/doi.org\/10.1186\/s40478-020-01094-2","journal-title":"Acta Neuropathol Commun"},{"key":"3533_CR33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bpa.12070","volume":"24","author":"C-Y Ho","year":"2014","unstructured":"Ho C-Y, Troncoso JC, Knox D et al (2014) Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients. Brain Pathol Zurich Switz 24:25\u201332. https:\/\/doi.org\/10.1111\/bpa.12070","journal-title":"Brain Pathol Zurich Switz"},{"key":"3533_CR34","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3233\/JAD-160823","volume":"56","author":"G Chidlow","year":"2017","unstructured":"Chidlow G, Wood JPM, Manavis J et al (2017) Investigations into retinal pathology in the early stages of a mouse model of Alzheimer\u2019s disease. J Alzheimers Dis 56:655\u2013675. https:\/\/doi.org\/10.3233\/JAD-160823","journal-title":"J Alzheimers Dis"},{"key":"3533_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/0006-8993(89)90653-7","volume":"501","author":"JC Blanks","year":"1989","unstructured":"Blanks JC, Hinton DR, Sadun AA, Miller CA (1989) Retinal ganglion cell degeneration in Alzheimer\u2019s disease. Brain Res 501:364\u2013372. https:\/\/doi.org\/10.1016\/0006-8993(89)90653-7","journal-title":"Brain Res"},{"key":"3533_CR36","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1007\/s12035-021-02316-x","volume":"58","author":"AC Rodrigues-Neves","year":"2021","unstructured":"Rodrigues-Neves AC, Carecho R, Correia SC et al (2021) Retina and brain display early and differential molecular and cellular changes in the 3xTg-AD mouse model of Alzheimer\u2019s disease. Mol Neurobiol 58:3043\u20133060. https:\/\/doi.org\/10.1007\/s12035-021-02316-x","journal-title":"Mol Neurobiol"},{"key":"3533_CR37","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/glia.20967","volume":"58","author":"M Olabarria","year":"2010","unstructured":"Olabarria M, Noristani HN, Verkhratsky A, Rodr\u00edguez JJ (2010) Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer\u2019s disease. Glia 58:831\u2013838. https:\/\/doi.org\/10.1002\/glia.20967","journal-title":"Glia"},{"key":"3533_CR38","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41419-018-0740-5","volume":"9","author":"A Grimaldi","year":"2018","unstructured":"Grimaldi A, Brighi C, Peruzzi G et al (2018) Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer\u2019s disease in the 3xTg-AD mouse model. Cell Death Dis 9:685. https:\/\/doi.org\/10.1038\/s41419-018-0740-5","journal-title":"Cell Death Dis"},{"key":"3533_CR39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.exer.2014.08.006","volume":"127","author":"MM Edwards","year":"2014","unstructured":"Edwards MM, Rodr\u00edguez JJ, Gutierrez-Lanza R et al (2014) Retinal macroglia changes in a triple transgenic mouse model of Alzheimer\u2019s disease. Exp Eye Res 127:252\u2013260. https:\/\/doi.org\/10.1016\/j.exer.2014.08.006","journal-title":"Exp Eye Res"},{"key":"3533_CR40","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13195-019-0542-8","volume":"11","author":"S Chiquita","year":"2019","unstructured":"Chiquita S, Campos EJ, Castelhano J et al (2019) Retinal thinning of inner sub-layers is associated with cortical atrophy in a mouse model of Alzheimer\u2019s disease: a longitudinal multimodal in vivo study. Alzheimers Res Ther 11:90. https:\/\/doi.org\/10.1186\/s13195-019-0542-8","journal-title":"Alzheimers Res Ther"},{"key":"3533_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jprot.2015.04.005","volume":"123","author":"L Shen","year":"2015","unstructured":"Shen L, Chen C, Yang A et al (2015) Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer\u2019s disease mice at its earliest pathological stage. J Proteomics 123:101\u2013113. https:\/\/doi.org\/10.1016\/j.jprot.2015.04.005","journal-title":"J Proteomics"},{"key":"3533_CR42","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1021\/acschemneuro.8b00710","volume":"10","author":"J Iqbal","year":"2019","unstructured":"Iqbal J, Zhang K, Jin N et al (2019) Alzheimer\u2019s disease is responsible for progressive age-dependent differential expression of various protein cascades in retina of mice. ACS Chem Neurosci 10:2418\u20132433. https:\/\/doi.org\/10.1021\/acschemneuro.8b00710","journal-title":"ACS Chem Neurosci"},{"key":"3533_CR43","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/jnr.24750","volume":"99","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Chen H, Iqbal J et al (2021) Targeted metabolomics study of early pathological features in hippocampus of triple transgenic Alzheimer\u2019s disease male mice. J Neurosci Res 99:927\u2013946. https:\/\/doi.org\/10.1002\/jnr.24750","journal-title":"J Neurosci Res"},{"key":"3533_CR44","first-page":"263","volume-title":"microbial metabolomics","author":"Y Cai","year":"2019","unstructured":"Cai Y, Zhu Z-J (2019) A high-throughput targeted metabolomics workflow for the detection of 200 polar metabolites in central carbon metabolism. In: Baidoo EEK (ed) microbial metabolomics. Springer, New York, New York, NY, pp 263\u2013274"},{"key":"3533_CR45","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1007\/s11306-015-0809-4","volume":"11","author":"Y Cai","year":"2015","unstructured":"Cai Y, Weng K, Guo Y et al (2015) An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing. Metabolomics 11:1575\u20131586. https:\/\/doi.org\/10.1007\/s11306-015-0809-4","journal-title":"Metabolomics"},{"key":"3533_CR46","doi-asserted-by":"publisher","first-page":"W388","DOI":"10.1093\/nar\/gkab382","volume":"49","author":"Z Pang","year":"2021","unstructured":"Pang Z, Chong J, Zhou G et al (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49:W388\u2013W396. https:\/\/doi.org\/10.1093\/nar\/gkab382","journal-title":"Nucleic Acids Res"},{"key":"3533_CR47","doi-asserted-by":"publisher","unstructured":"Sumanta B, William D, Evans CR et al (2017) Sparse network modeling and metscape-based visualization methods for the analysis of large-scale metabolomics data. Bioinformatics 1545\u20131553. https:\/\/doi.org\/10.1093\/bioinformatics\/btx012","DOI":"10.1093\/bioinformatics\/btx012"},{"key":"3533_CR48","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41598-018-37312-0","volume":"9","author":"SD Creighton","year":"2019","unstructured":"Creighton SD, Mendell AL, Palmer D et al (2019) Dissociable cognitive impairments in two strains of transgenic Alzheimer\u2019s disease mice revealed by a battery of object-based tests. Sci Rep 9:57. https:\/\/doi.org\/10.1038\/s41598-018-37312-0","journal-title":"Sci Rep"},{"key":"3533_CR49","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.9.5.18","volume":"9","author":"MR Gardner","year":"2020","unstructured":"Gardner MR, Baruah V, Vargas G et al (2020) Scattering angle resolved optical coherence tomography detects early changes in 3xTg Alzheimer\u2019s disease mouse model. Transl Vis Sci Technol 9:18. https:\/\/doi.org\/10.1167\/tvst.9.5.18","journal-title":"Transl Vis Sci Technol"},{"key":"3533_CR50","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/bpa.12592","volume":"28","author":"P Alonso-Andr\u00e9s","year":"2018","unstructured":"Alonso-Andr\u00e9s P, Albasanz JL, Ferrer I, Mart\u00edn M (2018) Purine-related metabolites and their converting enzymes are altered in frontal, parietal and temporal cortex at early stages of Alzheimer\u2019s disease pathology. Brain Pathol Zurich Switz 28:933\u2013946. https:\/\/doi.org\/10.1111\/bpa.12592","journal-title":"Brain Pathol Zurich Switz"},{"key":"3533_CR51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s12035-014-8884-5","volume":"52","author":"Z Xiang","year":"2015","unstructured":"Xiang Z, Xu M, Liao M et al (2015) Integrating genome-wide association study and brain expression data highlights cell adhesion molecules and purine metabolism in Alzheimer\u2019s disease. Mol Neurobiol 52:514\u2013521. https:\/\/doi.org\/10.1007\/s12035-014-8884-5","journal-title":"Mol Neurobiol"},{"key":"3533_CR52","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Rozen S, Matson W et al (2011) Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement J Alzheimers Assoc 7:309\u2013317. https:\/\/doi.org\/10.1016\/j.jalz.2010.06.001","journal-title":"Alzheimers Dement J Alzheimers Assoc"},{"key":"3533_CR53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/NEN.0000000000000091","volume":"73","author":"M Jov\u00e9","year":"2014","unstructured":"Jov\u00e9 M, Portero-Ot\u00edn M, Naud\u00ed A et al (2014) Metabolomics of human brain aging and age-related neurodegenerative diseases. J Neuropathol Exp Neurol 73:640\u2013657. https:\/\/doi.org\/10.1097\/NEN.0000000000000091","journal-title":"J Neuropathol Exp Neurol"},{"key":"3533_CR54","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.1038\/tp.2013.18","volume":"3","author":"R Kaddurah-Daouk","year":"2013","unstructured":"Kaddurah-Daouk R, Zhu H, Sharma S et al (2013) Alterations in metabolic pathways and networks in Alzheimer\u2019s disease. Transl Psychiatry 3:e244. https:\/\/doi.org\/10.1038\/tp.2013.18","journal-title":"Transl Psychiatry"},{"key":"3533_CR55","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2014.08.004","volume":"36","author":"B Ansoleaga","year":"2015","unstructured":"Ansoleaga B, Jov\u00e9 M, Schl\u00fcter A et al (2015) Deregulation of purine metabolism in Alzheimer\u2019s disease. Neurobiol Aging 36:68\u201380. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.08.004","journal-title":"Neurobiol Aging"},{"key":"3533_CR56","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11306-021-01793-4","volume":"17","author":"H Dejakaisaya","year":"2021","unstructured":"Dejakaisaya H, Harutyunyan A, Kwan P, Jones NC (2021) Altered metabolic pathways in a transgenic mouse model suggest mechanistic role of amyloid precursor protein overexpression in Alzheimer\u2019s disease. Metabolomics Off J Metabolomic Soc 17:42. https:\/\/doi.org\/10.1007\/s11306-021-01793-4","journal-title":"Metabolomics Off J Metabolomic Soc"},{"key":"3533_CR57","doi-asserted-by":"publisher","unstructured":"Muguruma Y, Tsutsui H, Akatsu H, Inoue K (2020) Comprehensive quantification of purine and pyrimidine metabolism in Alzheimer\u2019s disease postmortem cerebrospinal fluid by LC\u2013MS\/MS with metal\u2010free column. Biomed Chromatogr 34:. https:\/\/doi.org\/10.1002\/bmc.4722","DOI":"10.1002\/bmc.4722"},{"key":"3533_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jpba.2014.10.009","volume":"102","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, Vitorica J, G\u00f3mez-Ariza JL (2015) Metabolomic screening of regional brain alterations in the APP\/PS1 transgenic model of Alzheimer\u2019s disease by direct infusion mass spectrometry. J Pharm Biomed Anal 102:425\u2013435. https:\/\/doi.org\/10.1016\/j.jpba.2014.10.009","journal-title":"J Pharm Biomed Anal"},{"key":"3533_CR59","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/nar\/gkv047","volume":"43","author":"AN Lane","year":"2015","unstructured":"Lane AN, Fan TW-M (2015) Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res 43:2466\u20132485. https:\/\/doi.org\/10.1093\/nar\/gkv047","journal-title":"Nucleic Acids Res"},{"key":"3533_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.exer.2019.03.007","volume":"184","author":"ER Weiss","year":"2019","unstructured":"Weiss ER, Osawa S, Xiong Y et al (2019) Broad spectrum metabolomics for detection of abnormal metabolic pathways in a mouse model for retinitis pigmentosa. Exp Eye Res 184:135\u2013145. https:\/\/doi.org\/10.1016\/j.exer.2019.03.007","journal-title":"Exp Eye Res"},{"key":"3533_CR61","doi-asserted-by":"publisher","unstructured":"Wan Y, Zhang Q, Zhang Z et al (2016) Transcriptome analysis reveals a ribosome constituents disorder involved in the RPL5 downregulated zebrafish model of Diamond-Blackfan anemia. BMC Med Genomics 9:. https:\/\/doi.org\/10.1186\/s12920-016-0174-9","DOI":"10.1186\/s12920-016-0174-9"},{"key":"3533_CR62","first-page":"1104","volume":"16","author":"Y Matuk","year":"1977","unstructured":"Matuk Y, Lou P, Parker JA (1977) Biosynthesis of proteins by the retina. Inactivation by near-ultraviolet light and the effects of tryptophan, epinephrine, and catalase. Invest Ophthalmol Vis Sci 16:1104\u20131109","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3533_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000265262","volume":"15","author":"JF Kuck","year":"1983","unstructured":"Kuck JF (1983) Effect of long-wave ultraviolet light on the lens. IV. Leucine metabolism in normal human lenses in vitro. Ophthalmic Res 15:216\u2013219. https:\/\/doi.org\/10.1159\/000265262","journal-title":"Ophthalmic Res"},{"key":"3533_CR64","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina E, Dutta T, Persson X-MT et al (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PloS One 8:e63644. https:\/\/doi.org\/10.1371\/journal.pone.0063644","journal-title":"PloS One"},{"key":"3533_CR65","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1007\/s12035-020-02271-z","volume":"58","author":"Q Zheng","year":"2021","unstructured":"Zheng Q, Bi R, Xu M et al (2021) Exploring the genetic association of the ABAT gene with Alzheimer\u2019s disease. Mol Neurobiol 58:1894\u20131903. https:\/\/doi.org\/10.1007\/s12035-020-02271-z","journal-title":"Mol Neurobiol"},{"key":"3533_CR66","doi-asserted-by":"publisher","first-page":"E1813","DOI":"10.3390\/ijms18081813","volume":"18","author":"K Govindpani","year":"2017","unstructured":"Govindpani K, Calvo-Flores Guzm\u00e1n B, Vinnakota C et al (2017) Towards a better understanding of GABAergic remodeling in Alzheimer\u2019s disease. Int J Mol Sci 18:E1813. https:\/\/doi.org\/10.3390\/ijms18081813","journal-title":"Int J Mol Sci"},{"key":"3533_CR67","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1007\/s00213-016-4259-0","volume":"233","author":"TA Shnitko","year":"2016","unstructured":"Shnitko TA, Taylor SC, Stringfield SJ et al (2016) Acute phenylalanine\/tyrosine depletion of phasic dopamine in the rat brain. Psychopharmacology 233:2045\u20132054. https:\/\/doi.org\/10.1007\/s00213-016-4259-0","journal-title":"Psychopharmacology"},{"key":"3533_CR68","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.nbd.2018.05.006","volume":"116","author":"A Cordella","year":"2018","unstructured":"Cordella A, Krashia P, Nobili A et al (2018) Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer\u2019s disease. Neurobiol Dis 116:142\u2013154. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.006","journal-title":"Neurobiol Dis"},{"key":"3533_CR69","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jpba.2014.10.010","volume":"107","author":"R Gonz\u00e1lez-Dom\u00ednguez","year":"2015","unstructured":"Gonz\u00e1lez-Dom\u00ednguez R, Garc\u00eda-Barrera T, G\u00f3mez-Ariza JL (2015) Metabolite profiling for the identification of altered metabolic pathways in Alzheimer\u2019s disease. J Pharm Biomed Anal 107:75\u201381. https:\/\/doi.org\/10.1016\/j.jpba.2014.10.010","journal-title":"J Pharm Biomed Anal"},{"key":"3533_CR70","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E, Pawlak K, Bien B, Pawlak D (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55:204\u2013211. https:\/\/doi.org\/10.2478\/v10039-010-0023-6","journal-title":"Adv Med Sci"},{"key":"3533_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-021-01052-z","author":"L Shen","year":"2021","unstructured":"Shen L, Yang A, Chen X et al (2021) Proteomic profiling of cerebrum mitochondria, myelin sheath, and synaptosome revealed mitochondrial damage and synaptic impairments in association with 3 \u00d7 Tg-AD mice model. Cell Mol Neurobiol. https:\/\/doi.org\/10.1007\/s10571-021-01052-z","journal-title":"Cell Mol Neurobiol"},{"key":"3533_CR72","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.3233\/JAD-160702","volume":"57","author":"L Guo","year":"2017","unstructured":"Guo L, Tian J, Du H (2017) Mitochondrial dysfunction and synaptic transmission failure in Alzheimer\u2019s disease. J Alzheimers Dis 57:1071\u20131086. https:\/\/doi.org\/10.3233\/JAD-160702","journal-title":"J Alzheimers Dis"},{"key":"3533_CR73","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1021\/acschemneuro.0c00549","volume":"12","author":"X Du","year":"2021","unstructured":"Du X, Shi Q, Zhao Y et al (2021) Se-methylselenocysteine (SMC) improves cognitive deficits by attenuating synaptic and metabolic abnormalities in Alzheimer\u2019s mice model: a proteomic study. ACS Chem Neurosci 12:1112\u20131132. https:\/\/doi.org\/10.1021\/acschemneuro.0c00549","journal-title":"ACS Chem Neurosci"},{"key":"3533_CR74","doi-asserted-by":"publisher","first-page":"E974","DOI":"10.3390\/ijms20040974","volume":"20","author":"V Gasperi","year":"2019","unstructured":"Gasperi V, Sibilano M, Savini I, Catani MV (2019) Niacin in the central nervous system: an update of biological aspects and clinical applications. Int J Mol Sci 20:E974. https:\/\/doi.org\/10.3390\/ijms20040974","journal-title":"Int J Mol Sci"},{"key":"3533_CR75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.maturitas.2016.08.001","volume":"93","author":"K Mikkelsen","year":"2016","unstructured":"Mikkelsen K, Stojanovska L, Tangalakis K et al (2016) Cognitive decline: a vitamin B perspective. Maturitas 93:108\u2013113. https:\/\/doi.org\/10.1016\/j.maturitas.2016.08.001","journal-title":"Maturitas"},{"key":"3533_CR76","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/jnnp.2003.025858","volume":"75","author":"MC Morris","year":"2004","unstructured":"Morris MC (2004) Dietary niacin and the risk of incident Alzheimer\u2019s disease and of cognitive decline. J Neurol Neurosurg Psychiatry 75:1093\u20131099. https:\/\/doi.org\/10.1136\/jnnp.2003.025858","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3533_CR77","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1126\/science.aal0092","volume":"355","author":"PA Williams","year":"2017","unstructured":"Williams PA, Harder JM, Foxworth NE et al (2017) Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice. Science 355:756\u2013760. https:\/\/doi.org\/10.1126\/science.aal0092","journal-title":"Science"},{"key":"3533_CR78","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.neurobiolaging.2012.11.020","volume":"34","author":"D Liu","year":"2013","unstructured":"Liu D, Pitta M, Jiang H et al (2013) Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol Aging 34:1564\u20131580. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2012.11.020","journal-title":"Neurobiol Aging"},{"key":"3533_CR79","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.bbrc.2020.05.015","volume":"527","author":"J Xu","year":"2020","unstructured":"Xu J, Patassini S, Begley P et al (2020) Cerebral deficiency of vitamin B5 (d-pantothenic acid; pantothenate) as a potentially-reversible cause of neurodegeneration and dementia in sporadic Alzheimer\u2019s disease. Biochem Biophys Res Commun 527:676\u2013681. https:\/\/doi.org\/10.1016\/j.bbrc.2020.05.015","journal-title":"Biochem Biophys Res Commun"},{"key":"3533_CR80","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo JB, Arnold M, Kastenm\u00fcller G et al (2017) Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimers Dement 13:965\u2013984. https:\/\/doi.org\/10.1016\/j.jalz.2017.01.020","journal-title":"Alzheimers Dement"},{"key":"3533_CR81","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dadm.2017.07.006","volume":"8","author":"FA Leeuw","year":"2017","unstructured":"Leeuw FA, Peeters CFW, Kester MI et al (2017) Blood-based metabolic signatures in Alzheimer\u2019s disease. Alzheimers Dement Diagn Assess Dis Monit 8:196\u2013207. https:\/\/doi.org\/10.1016\/j.dadm.2017.07.006","journal-title":"Alzheimers Dement Diagn Assess Dis Monit"},{"key":"3533_CR82","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.biopsych.2020.09.025","volume":"89","author":"BD Needham","year":"2021","unstructured":"Needham BD, Adame MD, Serena G et al (2021) Plasma and fecal metabolite profiles in autism spectrum disorder. Biol Psychiatry 89:451\u2013462. https:\/\/doi.org\/10.1016\/j.biopsych.2020.09.025","journal-title":"Biol Psychiatry"},{"key":"3533_CR83","first-page":"313","volume":"21","author":"RN Nishimura","year":"2000","unstructured":"Nishimura RN, Santos D, Fu ST, Dwyer BE (2000) Induction of cell death by L-alpha-aminoadipic acid exposure in cultured rat astrocytes: relationship to protein synthesis. Neurotoxicology 21:313\u2013320","journal-title":"Neurotoxicology"},{"key":"3533_CR84","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12974-021-02117-y","volume":"18","author":"N Davis","year":"2021","unstructured":"Davis N, Mota BC, Stead L et al (2021) Pharmacological ablation of astrocytes reduces A\u03b2 degradation and synaptic connectivity in an ex vivo model of Alzheimer\u2019s disease. J Neuroinflammation 18:73. https:\/\/doi.org\/10.1186\/s12974-021-02117-y","journal-title":"J Neuroinflammation"},{"key":"3533_CR85","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.optom.2018.07.001","volume":"12","author":"JA Fern\u00e1ndez-Albarral","year":"2019","unstructured":"Fern\u00e1ndez-Albarral JA, Salobrar-Garc\u00eda E, Mart\u00ednez-P\u00e1ramo R et al (2019) Retinal glial changes in Alzheimer\u2019s disease \u2014 a review. J Optom 12:198\u2013207. https:\/\/doi.org\/10.1016\/j.optom.2018.07.001","journal-title":"J Optom"},{"key":"3533_CR86","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Tr\u00e9panier MO et al (2018) Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry 23:177\u2013198. https:\/\/doi.org\/10.1038\/mp.2017.246","journal-title":"Mol Psychiatry"},{"key":"3533_CR87","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fnagi.2017.00214","volume":"9","author":"AI Ramirez","year":"2017","unstructured":"Ramirez AI, de Hoz R, Salobrar-Garcia E et al (2017) The role of microglia in retinal neurodegeneration: Alzheimer\u2019s disease, Parkinson, and glaucoma. Front Aging Neurosci 9:214. https:\/\/doi.org\/10.3389\/fnagi.2017.00214","journal-title":"Front Aging Neurosci"},{"key":"3533_CR88","doi-asserted-by":"publisher","first-page":"816","DOI":"10.3390\/ijms21030816","volume":"21","author":"E Salobrar-Garc\u00eda","year":"2020","unstructured":"Salobrar-Garc\u00eda E, Rodrigues-Neves AC, Ram\u00edrez AI et al (2020) Microglial activation in the retina of a triple-transgenic Alzheimer\u2019s disease mouse model (3xTg-AD). Int J Mol Sci 21:816. https:\/\/doi.org\/10.3390\/ijms21030816","journal-title":"Int J Mol Sci"},{"key":"3533_CR89","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/s41419-021-04237-y","volume":"12","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Skotte NH, Christensen SK et al (2021) Hippocampal disruptions of synaptic and astrocyte metabolism are primary events of early amyloid pathology in the 5xFAD mouse model of Alzheimer\u2019s disease. Cell Death Dis 12:954. https:\/\/doi.org\/10.1038\/s41419-021-04237-y","journal-title":"Cell Death Dis"},{"key":"3533_CR90","doi-asserted-by":"publisher","first-page":"105874","DOI":"10.1016\/j.nbd.2022.105874","volume":"174","author":"R Afridi","year":"2022","unstructured":"Afridi R, Rahman MH, Suk K (2022) Implications of glial metabolic dysregulation in the pathophysiology of neurodegenerative diseases. Neurobiol Dis 174:105874. https:\/\/doi.org\/10.1016\/j.nbd.2022.105874","journal-title":"Neurobiol Dis"},{"key":"3533_CR91","doi-asserted-by":"publisher","first-page":"105198","DOI":"10.1016\/j.nbd.2020.105198","volume":"148","author":"JV Andersen","year":"2021","unstructured":"Andersen JV, Christensen SK, Westi EW et al (2021) Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer\u2019s disease. Neurobiol Dis 148:105198. https:\/\/doi.org\/10.1016\/j.nbd.2020.105198","journal-title":"Neurobiol Dis"},{"key":"3533_CR92","doi-asserted-by":"publisher","first-page":"e0175369","DOI":"10.1371\/journal.pone.0175369","volume":"12","author":"M van Gijsel-Bonnello","year":"2017","unstructured":"van Gijsel-Bonnello M, Baranger K, Benech P et al (2017) Metabolic changes and inflammation in cultured astrocytes from the 5xFAD mouse model of Alzheimer\u2019s disease: alleviation by pantethine. PLOS One 12:e0175369. https:\/\/doi.org\/10.1371\/journal.pone.0175369","journal-title":"PLOS One"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-023-03533-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-023-03533-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:34:08Z","timestamp":1700494448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-023-03533-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":92,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["3533"],"URL":"https:\/\/doi.org\/10.1007\/s12035-023-03533-2","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were authorized by the Ethic Committee of Shenzhen University (certificate number: AEWC-20140615\u2013002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}